Npl4 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Npl4 monoclonal antibodies for research focused on understanding protein quality control and cellular homeostasis. Npl4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Npl4 functions as a critical component of the ubiquitin-proteasome system, maintaining cellular health through the recognition and processing of misfolded proteins. The role of Npl4 extends to regulating cell cycle progression and coordinating cellular stress responses. Research has shown that Npl4 activity significantly impacts various disease pathways, particularly in cancer and neurodegenerative disorders. Investigating Npl4 mechanisms provides valuable insights into protein degradation pathways and their influence on cellular function. Understanding how Npl4 operates within the ubiquitin-proteasome system can reveal new therapeutic approaches for disease treatment. Researchers can explore complex cellular mechanisms and contribute to breakthrough discoveries in protein quality control using Santa Cruz Biotechnology monoclonal antibodies.